Life span profiles of glutathione and acetaminophen detoxification

T. S. Chen, John Richie, C. A. Lang

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Our previous finding of a glutathione (GSH) deficiency in aging or senescent mice suggested that a concomitant decrease in detoxification capacity also may occur. To test this, mice at different biological stages of the life span (growth, maturity, aging or senescence) were injected with various doses of acetaminophen (APAP), and GSH depletion and recovery rates were determined. At intervals for 24 hr, samples of blood and other tissue were obtained, processed, and analyzed for reduced GSH, glutathione disulfide (GSSG), cysteine, and cystine using HPLC with dual electrochemical detection. In the uninjected controls, the GD~GSH concentration decreases about 30% in all tissues of the aging mouse, but the GSSG cysteine, and cystine levels were unchanged during the life span. APAP administration depleted liver and lung GSH contents in a dose- and time-dependent manner. Four hr after APAP administration, hepatic GSH levels of all ages had decreased 70-80%. After 24 hr, the GSH levels of the young, growing (3-6 months), and mature (12 months) mice recovered to 94 and 66%, respectively, of the controls. In contrast, the level in aging (31 months) mice rose only 41%, a lower recovery that was correlated with their decreased GSH content. The lungs of old mice also were GSH-deficient but differed from liver, for there was less GSH depletion by APAP and no decrease in GSH recovery. Thus, these findings demonstrate clearly the occurrence of decreased detoxification capacity in the GSH-deficient, aging mouse.

Original languageEnglish (US)
Pages (from-to)882-887
Number of pages6
JournalDrug Metabolism and Disposition
Volume18
Issue number6
StatePublished - Dec 1 1990

Fingerprint

Acetaminophen
Glutathione Disulfide
Cystine
Glutathione
Cysteine
Liver
Lung
3-(glutathion-S-yl)acetaminophen
High Pressure Liquid Chromatography
Growth

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

@article{a389df0c7a5e4d4f9976f1a6be9b0ec8,
title = "Life span profiles of glutathione and acetaminophen detoxification",
abstract = "Our previous finding of a glutathione (GSH) deficiency in aging or senescent mice suggested that a concomitant decrease in detoxification capacity also may occur. To test this, mice at different biological stages of the life span (growth, maturity, aging or senescence) were injected with various doses of acetaminophen (APAP), and GSH depletion and recovery rates were determined. At intervals for 24 hr, samples of blood and other tissue were obtained, processed, and analyzed for reduced GSH, glutathione disulfide (GSSG), cysteine, and cystine using HPLC with dual electrochemical detection. In the uninjected controls, the GD~GSH concentration decreases about 30{\%} in all tissues of the aging mouse, but the GSSG cysteine, and cystine levels were unchanged during the life span. APAP administration depleted liver and lung GSH contents in a dose- and time-dependent manner. Four hr after APAP administration, hepatic GSH levels of all ages had decreased 70-80{\%}. After 24 hr, the GSH levels of the young, growing (3-6 months), and mature (12 months) mice recovered to 94 and 66{\%}, respectively, of the controls. In contrast, the level in aging (31 months) mice rose only 41{\%}, a lower recovery that was correlated with their decreased GSH content. The lungs of old mice also were GSH-deficient but differed from liver, for there was less GSH depletion by APAP and no decrease in GSH recovery. Thus, these findings demonstrate clearly the occurrence of decreased detoxification capacity in the GSH-deficient, aging mouse.",
author = "Chen, {T. S.} and John Richie and Lang, {C. A.}",
year = "1990",
month = "12",
day = "1",
language = "English (US)",
volume = "18",
pages = "882--887",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "6",

}

Life span profiles of glutathione and acetaminophen detoxification. / Chen, T. S.; Richie, John; Lang, C. A.

In: Drug Metabolism and Disposition, Vol. 18, No. 6, 01.12.1990, p. 882-887.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Life span profiles of glutathione and acetaminophen detoxification

AU - Chen, T. S.

AU - Richie, John

AU - Lang, C. A.

PY - 1990/12/1

Y1 - 1990/12/1

N2 - Our previous finding of a glutathione (GSH) deficiency in aging or senescent mice suggested that a concomitant decrease in detoxification capacity also may occur. To test this, mice at different biological stages of the life span (growth, maturity, aging or senescence) were injected with various doses of acetaminophen (APAP), and GSH depletion and recovery rates were determined. At intervals for 24 hr, samples of blood and other tissue were obtained, processed, and analyzed for reduced GSH, glutathione disulfide (GSSG), cysteine, and cystine using HPLC with dual electrochemical detection. In the uninjected controls, the GD~GSH concentration decreases about 30% in all tissues of the aging mouse, but the GSSG cysteine, and cystine levels were unchanged during the life span. APAP administration depleted liver and lung GSH contents in a dose- and time-dependent manner. Four hr after APAP administration, hepatic GSH levels of all ages had decreased 70-80%. After 24 hr, the GSH levels of the young, growing (3-6 months), and mature (12 months) mice recovered to 94 and 66%, respectively, of the controls. In contrast, the level in aging (31 months) mice rose only 41%, a lower recovery that was correlated with their decreased GSH content. The lungs of old mice also were GSH-deficient but differed from liver, for there was less GSH depletion by APAP and no decrease in GSH recovery. Thus, these findings demonstrate clearly the occurrence of decreased detoxification capacity in the GSH-deficient, aging mouse.

AB - Our previous finding of a glutathione (GSH) deficiency in aging or senescent mice suggested that a concomitant decrease in detoxification capacity also may occur. To test this, mice at different biological stages of the life span (growth, maturity, aging or senescence) were injected with various doses of acetaminophen (APAP), and GSH depletion and recovery rates were determined. At intervals for 24 hr, samples of blood and other tissue were obtained, processed, and analyzed for reduced GSH, glutathione disulfide (GSSG), cysteine, and cystine using HPLC with dual electrochemical detection. In the uninjected controls, the GD~GSH concentration decreases about 30% in all tissues of the aging mouse, but the GSSG cysteine, and cystine levels were unchanged during the life span. APAP administration depleted liver and lung GSH contents in a dose- and time-dependent manner. Four hr after APAP administration, hepatic GSH levels of all ages had decreased 70-80%. After 24 hr, the GSH levels of the young, growing (3-6 months), and mature (12 months) mice recovered to 94 and 66%, respectively, of the controls. In contrast, the level in aging (31 months) mice rose only 41%, a lower recovery that was correlated with their decreased GSH content. The lungs of old mice also were GSH-deficient but differed from liver, for there was less GSH depletion by APAP and no decrease in GSH recovery. Thus, these findings demonstrate clearly the occurrence of decreased detoxification capacity in the GSH-deficient, aging mouse.

UR - http://www.scopus.com/inward/record.url?scp=0025681755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025681755&partnerID=8YFLogxK

M3 - Article

C2 - 1981532

AN - SCOPUS:0025681755

VL - 18

SP - 882

EP - 887

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 6

ER -